Skip to main content
A kinase inhibitor for late-stage melanoma and its companion diagnostic test have been approved by the FDA.

Vemurafenib Tablets (Zelboraf™)

A kinase inhibitor for late-stage melanoma and its companion diagnostic test have been approved by the FDA.